Condition | Metabolic abnormality |
Tumours | |
Corticosterone secreting tumours | High concentrations of corticosterone |
Deoxycorticosterone secreting tumours | High concentrations of deoxycorticosterone33 |
Biosynthetic defects | |
17-Hydroxylase deficiency | High ratio of THF + αTHF/THE; low 17-hydroxycorticosterone concentrations34 |
11-Hydroxylase deficiency | Little or no cortisol excretion35 |
Other conditions | |
Cushing's disease | High serum cortisol levels; high excretion of urinary free cortisol36 |
Mineralocorticoid excess syndrome | F:E ratio increased (cortisol to cortisone ratio increased)37 |
Dexamethasone suppressible hyperaldosteronism | High urinary excretion of 18-hydroxycortisol metabolites38 |
Partial glucocorticoid resistance | Total cortisol metabolites are increased |
F:E ratio, cortisol to cortisone ratio; THE, tetrahydrocortisone; THF, tetrahydrocortisol.